Eli Lilly and Company Blog | Talkmarkets

Latest Posts

About This Stock More About This Stock

5 Great S&P 500 Stocks To Buy In 2019

Article By: Swarup Gupta

Wednesday, January 2, 2019 12:12 PM EST

Despite the pessimism surrounding this year’s market prospects, things may not be as tricky as they seem.

In this article: TRIP, AAP, RHT, LLY, CRM Also: GS, MA

Read

Week In Review: Shanghai Industrial To Start $7.3 Billion Biomedical Fund In 2019

Article By: ChinaBio® Today

Saturday, December 29, 2018 4:08 PM EST

Shanghai Industrial Investment, a state-owned conglomerate, plans to launch a $7.3 billion equity fund for China biopharma investments. The company plans to begin raising $1.5 billion in January for the fund's first tranche.

In this article: AZN, LLY, FGEN

Read

Week In Review: BeiGene Forges $1.3 Billion Bi-Specific Antibody Deal With Zymeworks

Article By: ChinaBio® Today

Saturday, December 1, 2018 4:44 PM EST

BeiGene of Beijing announced cancer drug deals worth up to $1.3 billion with Vancouver's Zymeworks. BeiGene will acquire Asian rights to two bispecific antibodies from Zymeworks and will have rights to three to-be-discovered bispecific candidates.

In this article: LLY, HCM, BGNE, MGNX, ZLAB, TCON, ZYME, BHVN

Read

Week In Review: Alphamab Closes $100 Million Series A For Oncology Candidates

Article By: ChinaBio® Today

Saturday, November 24, 2018 4:09 PM EST

Alphamab Oncology, a clinical-stage Suzhou biopharma, completed a Series A funding with over $100 million in capital. Earlier this year, Alphamab Oncology was spun out of Suzhou Alphamab with seven oncology assets and related technology platforms.

In this article: LLY, CASI, BIIB, GILD

Read